Home / Fact sheets / Nicaragua / Cervical qualitative data

Country fact sheet: Nicaragua

CERVICAL CANCER SCREENING PROGRAMME

Reporting year for qualitative data: 2020
Source of qualitative data: Directly from Programme

Organization of screening

An individual/team/institution responsible to coordinate the programme: Yes
Dedicated budget for screening programme: Yes
Documented cancer screening policy: Yes
Nature of documentation of the policy: Law
Year programme was initiated: 1983
Programme introduction was preceded by a pilot: No
Screening tests provided free of charge: Yes
Diagnostic tests provided free of charge: Yes
Treatment services provided free of charge: Yes

Information system and data collection

System that collects data: Individual & Aggregated
   • Identification of eligible population: Individual
   • Screening participation: Individual & Aggregated
   • Screening test results: Individual & Aggregated
   • Further assessment: Individual & Aggregated
   • Final pathology diagnosis: Individual & Aggregated
   • Cancer staging: Individual & Aggregated
   • Treatment: Individual & Aggregated
The information system exists at national or sub-national level: Individual: National
Aggregated: National
The information system collects data outside the programme (opportunistic screening/private sector): Cannot differentiate
Cancer screening data is linked with population-based cancer registry (PBCR): No PBCR

Screening protocol

A screening protocol or guideline: Yes
Year of published/updated protocol: 2019
Target age (min-max) and screening interval [months] for each test: Cytology (15-99 years / [12 months])
Triaging test used: None
Self-collection HPV recommended: -
"Screen and treat" included in the protocol: No
Treatment modality for "screen and treat": -

Invitations for screening and further assessment

Initiatives to create population awareness by the Health Ministry/Health Authority: Mass media campaign
Small media campaign
Group education
One-on-one education
Invitations to eligible population: Yes
Source of the eligible individuals identified: Population register
List from GP or PHC
Method of invitation: Home visits by health workers
Screening kit included with the invitation: No
Screen positive individuals actively contacted for further assessment: Yes
Individuals with a precancer or cancer diagnosis actively contacted: Yes

Quality Assurance (QA) of screening activities

Documented standard operating procedure/policy for QA: Yes
An individual/team/institution responsible for QA: Yes
Accreditation of lab services: No
Accreditation of pathology services: No
Documented performance indicators: Yes
Reference standards for performance indicators: Yes
Evaluation reports published in the last five years: No

Performance indicators

Reporting year for quantitative data: 2019
Source of quantitative data: Directly from programme
Age range and regional limitation if applicable: 20-69 years
Invitation coverage (%): 39.6
Participation rate (%):
Examination coverage (%): 34.8
Completeness of data related to screening test results (%): 96.1
Completeness of data related to further assessment results (%): 2.1
Further assessment (Colposcopy referral) rate (%): 3.6
Further assessment participation rate (%): 50.8
Detection rate for CIN2+ (x 1000):
Detection rate for CIN3+ (x 1000):
Detection rate for invasive cancer (x 1000):
Positive Predictive Value of abnormal screening test to detect CIN2+ (x 1000):
Positive Predictive Value for CIN3+ (x 1000):
Positive Predictive Value for invasive cancer (x 1000):
More quantitative data (2019/Cytology)


Check also the following factsheets: Nicaragua, Breast, Colorectal